These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10099125)

  • 1. CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor.
    Barker E
    J Infect Dis; 1999 May; 179 Suppl 3():S485-8. PubMed ID: 10099125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individuals.
    Ahmed RK; Norrgren H; da Silva Z; Blaxhult A; Fredriksson EL; Biberfeld G; Andersson S; Thorstensson R
    Scand J Immunol; 2005 Jan; 61(1):63-71. PubMed ID: 15644124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.
    Bonneau KR; Ng S; Foster H; Choi KB; Berkhout B; Rabson A; Mackewicz CE; Levy JA
    Virology; 2008 Mar; 373(1):30-8. PubMed ID: 18086484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ T cell suppressor factors and the control of infection, replication and transcription of human immunodeficiency virus.
    Copeland KF
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):13-8. PubMed ID: 11266085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 lymphocytes in HIV infection: helpful and harmful.
    Famularo G; Moretti S; Marcellini S; Nucera E; De Simone C
    J Clin Lab Immunol; 1997; 49(1):15-32. PubMed ID: 9819670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals.
    Hsueh FW; Walker CM; Blackbourn DJ; Levy JA
    Cell Immunol; 1994 Dec; 159(2):271-9. PubMed ID: 7994759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
    Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM
    Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.
    Zhang L; Yu W; He T; Yu J; Caffrey RE; Dalmasso EA; Fu S; Pham T; Mei J; Ho JJ; Zhang W; Lopez P; Ho DD
    Science; 2002 Nov; 298(5595):995-1000. PubMed ID: 12351674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
    Oxenius A; Price DA; Trkola A; Edwards C; Gostick E; Zhang HT; Easterbrook PJ; Tun T; Johnson A; Waters A; Holmes EC; Phillips RE
    J Infect Dis; 2004 Aug; 190(4):713-21. PubMed ID: 15272399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.
    Faller E; Kakal J; Kumar R; Macpherson P
    Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine inhibits CD8+ T cell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells.
    Wang X; Tan N; Douglas SD; Zhang T; Wang YJ; Ho WZ
    J Leukoc Biol; 2005 Sep; 78(3):772-6. PubMed ID: 16000393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simian immunodeficiency viruses with defective nef genes show increased susceptibility to the noncytotoxic antiviral activity of CD8+ lymphocytes.
    Binninger-Schinzel D; Norley S; Adler HS; Oberg HH; Kurth R
    Virology; 2002 Mar; 294(1):209-21. PubMed ID: 11886279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
    Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
    J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High SDF-1 expression in HIV-1 carriers does not correlate with CD8+ T-cell-mediated suppression of viral replication.
    Ohashi T; Arai M; Kato H; Kubo M; Fujii M; Yamamoto N; Iwamoto A; Kannagi M
    Virology; 1998 May; 244(2):467-72. PubMed ID: 9601514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression.
    Dioszeghy V; Benlhassan-Chahour K; Delache B; Dereuddre-Bosquet N; Aubenque C; Gras G; Le Grand R; Vaslin B
    J Virol; 2006 Jan; 80(1):236-45. PubMed ID: 16352548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection.
    Lichterfeld M; Yu XG; Mui SK; Williams KL; Trocha A; Brockman MA; Allgaier RL; Waring MT; Koibuchi T; Johnston MN; Cohen D; Allen TM; Rosenberg ES; Walker BD; Altfeld M
    J Virol; 2007 Apr; 81(8):4199-214. PubMed ID: 17287271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
    Papasavvas E; Sandberg JK; Rutstein R; Moore EC; Mackiewicz A; Thiel B; Pistilli M; June RR; Jordan KA; Gross R; Maino VC; Nixon DF; Montaner LJ
    J Infect Dis; 2003 Sep; 188(6):873-82. PubMed ID: 12964119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.